MPM SunStates Fund, L.P. 4

Accession 0001209191-19-012245

CIK 0001750019other

View on SEC.gov Company Profile

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 6:05 PM ET

Size

20.1 KB

Accession

0001209191-19-012245

Insider Transaction Report

Form 4

Period: 2019-02-19

TCR2 THERAPEUTICS INC.TCRR

MPM SunStates GP Managing Member LLC

10% Owner

Transactions

Conversion
Common Stock
2019-02-19+322,901→ 3,344,199 total(indirect: See Footnote)
Conversion
Series B Preferred Stock
2019-02-19−2,000,000→ 0 total(indirect: See Footnote)
→ Common Stock (322,901 underlying)
Conversion
Common Stock
2019-02-19+2,825,396→ 3,021,298 total(indirect: See Footnote)
Purchase
Common Stock
2019-02-19$15.00/sh+706,666$10,599,990→ 4,050,865 total(indirect: See Footnote)
Conversion
Series A Preferred Stock
2019-02-19−17,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (2,825,396 underlying)

MPM Asset Management Investors SunStates Fund LLC

10% Owner

Transactions

Purchase
Common Stock
2019-02-19$15.00/sh+706,666$10,599,990→ 4,050,865 total(indirect: See Footnote)
Conversion
Series B Preferred Stock
2019-02-19−2,000,000→ 0 total(indirect: See Footnote)
→ Common Stock (322,901 underlying)
Conversion
Common Stock
2019-02-19+2,825,396→ 3,021,298 total(indirect: See Footnote)
Conversion
Common Stock
2019-02-19+322,901→ 3,344,199 total(indirect: See Footnote)
Conversion
Series A Preferred Stock
2019-02-19−17,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (2,825,396 underlying)

MPM SunStates Fund GP LLC

10% Owner

Transactions

Conversion
Common Stock
2019-02-19+2,825,396→ 3,021,298 total(indirect: See Footnote)
Conversion
Common Stock
2019-02-19+322,901→ 3,344,199 total(indirect: See Footnote)
Purchase
Common Stock
2019-02-19$15.00/sh+706,666$10,599,990→ 4,050,865 total(indirect: See Footnote)
Conversion
Series A Preferred Stock
2019-02-19−17,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (2,825,396 underlying)
Conversion
Series B Preferred Stock
2019-02-19−2,000,000→ 0 total(indirect: See Footnote)
→ Common Stock (322,901 underlying)

MPM SunStates Fund, L.P.

10% Owner

Transactions

Conversion
Common Stock
2019-02-19+2,825,396→ 3,021,298 total(indirect: See Footnote)
Conversion
Common Stock
2019-02-19+322,901→ 3,344,199 total(indirect: See Footnote)
Purchase
Common Stock
2019-02-19$15.00/sh+706,666$10,599,990→ 4,050,865 total(indirect: See Footnote)
Conversion
Series A Preferred Stock
2019-02-19−17,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (2,825,396 underlying)
Conversion
Series B Preferred Stock
2019-02-19−2,000,000→ 0 total(indirect: See Footnote)
→ Common Stock (322,901 underlying)

Footnotes (6)

[F1]All shares of Series A Preferred Stock and Series B Preferred Stock automatically converted into the number of shares of the Issuer's common stock on a 6.1938:1 basis, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
[F2]The Reporting Persons disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein.
[F3]The shares are held as follows: 2,195,681 by MPM BioVentures 2014, L.P. ("BV 2014"), 146,447 by MPM BioVentures 2014(B), L.P. ("BV 2014(B)"), 79,644 by MPM Asset Management Investors BV2014 LLC ("AM BV2014"), 195,902 by MPM Asset Management LLC ("AM LLC"), 351,155 by MPM SunStates Fund, L.P. ("MPM SunStates") and 52,469 by MPM Asset Management Investors Sunstates Fund LLC ("AM SunStates"). MPM BioVentures 2014 GP LLC and MPM BioVentures 2014 LLC ("BV LLC") are the direct and indirect general partners of BV 2014 and BV 2014(B). MPM SunStates Fund GP LLC and MPM SunStates GP Managing Member LLC ("SunStates GP") are the direct and indirect general partners of MPM SunStates. Luke Evnin, Ansbert Gadicke and Todd Foley are the managing directors of BV LLC, Ansbert Gadicke is a member of SunStates GP and Luke Evnin and Anbsert Gadicke are the members of AM LLC.
[F4]The shares are held as follows: 2,451,844 by BV 2014, 163,532 by BV 2014(B), 88,935 by AM BV2014, 195,902 by AM LLC, 386,270 by MPM SunStates and 57,716 by AM SunStates.
[F5]The shares are held as follows: 3,056,272 by BV 2014, 203,846 by BV 2014(B), 110,859 by AM BV2014, 195,902 by AM LLC, 421,070 by MPM SunStates and 62,916 by AM SunStates.
[F6]No securities held by the Reporting Persons.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

TCR2 THERAPEUTICS INC.

CIK 0001750019

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001765022

Filing Metadata

Form type: 4
Filed: Feb 20, 7:00 PM ET
Accepted: Feb 21, 6:05 PM ET
Size: 20.1 KB

View on SEC.gov